At a trendy venue near the San Francisco pier, Sam Altman’s verification project World celebrated its next evolution and rapid expansion of its ambitions. And it’s starting with Tinder. Tools for ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...

A consortium of JGC, Technip Energies and Samsung Heavy Industries has launched bidding for the module work on a second floating liquefied natural gas (FLNG) unit set for deployment offshore ...

When you think of GLP-1s and investing, the two large pharmaceutical companies benefiting most from this trend may first come to mind. First, there's Novo Nordisk, the first to bring GLP-1 weight loss ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Viking Therepeutics' VK2735 candidate is a dark horse contender among GLP-1 weight loss drugs. If upcoming late-stage clinical trial results prove positive, Viking's value as a takeover target could ...

ORANGEBURG, S.C. — Construction is now underway on a new biotechnology and innovation center at Claflin University, a project leaders say will transform how students learn and prepare for future ...

Sam Gallagher might feel the final stage of the season comes at the wrong time for him – two games into his latest comeback from injury Stoke City are now on an international break and will return ...

Vestal Point acquired 4,500,000 shares of Terns Pharmaceuticals in the fourth quarter. The quarter-end position value increased by $181.80 million as a result of this purchase, which created a new ...